@FiercePharma: Launch angst among investors, analysts say: 'People are all freaked out'--Reuters. Article | Follow @FiercePharma
> The combination of GlaxoSmithKline's ($GSK) Tykerb and Roche's ($RHHBY) Herceptin was almost two times as effective for invasive breast cancer as single-drug therapy. News
> Roche's Genentech unit is prepping for a Jan. 30 trial of claims that its psoriasis drug Raptiva caused fatal infections in some patients. Report
> A union fund sued Walgreen Co. and Par Pharmaceuticals, alleging that they conspired to overcharge for generic drugs. Story
> The World Health Organization warned India that IMS Health data used to gauge drug prices presents "a major problem" because it doesn't account for rebates and other discounts. Article
> Denmark's Lundbeck launched its antipsychotic drug Sycrest in the U.K. for bipolar I; it's sold as Saphris in the U.S. by Merck ($MRK). Report
> The influential labor union AFSCME has targeted Johnson & Johnson ($JNJ) as part of its proxy campaign to split the roles of chairman and chief executive at 7 major companies. News
> China's Sanjiu Pharma plans to spend 600 million to 700 million yuan on a 99% stake in Shandong Sunfeng Pharamceutical to augment its medicated skincare market, Shanghai Securities reports. More
> Indian drugmaker Dishman Pharmaceuticals said its Swiss unit bought the French contract research and manufacturing company Creapharm Parenterals. Article
> Dishman Netherlands inked a deal with Charles Bowman and Co. to distribute Vitamin D3 products in North America. Story
Biotech News
@FierceBiotech: Constellation inks $95M discovery deal, buyout option with Genentech on new epigenetic drug programs. News | Follow @FierceBiotech
@JohnCFierce: Say goodnight, gracie. Dimebon fails final Ph3, Pfizer dumps monster partnership. Release | Follow @JohnCFierce
@MarkHFierce: Researchers are challenging studies that linked hormone replacement therapy to cancer based on "flawed" data. More | Follow @MarkHFierce
> The 10 biotech IPOs of 2011. Report
> Fledgling Verastem outlines investor strategy behind high-risk $50M IPO. Story
> Constellation inks $95M discovery deal, buyout option with Genentech. News
Biotech Research News
> Sugar molecules betray precancerous cells in esophagus. More
> Hormone irisin eyed as possible weight loss drug ingredient. Item
> Vitamin D helps (more than) 3 (nearly) blind mice see. Article
> PARP inhibitors could aid larger ovarian cancer patient population. News
> Altering intestional bacteria with probiotics improved rats' heart health. Story
Manufacturing News
> Roche pilots direct shipments to Europe. News
> Abbott dodges excise tax at Indian plant. Story
> Daiichi sends Japanese execs to new Ranbaxy plant in India. More
> FDA: Novartis plant shows patterns of problems. Story
> USP has credibility as pedigree driver. Article
IT News
> Cannabis company launches Jane-Ome app. Item
> PerkinElmer CEO arranges marriage between informatics, lab service biz. More
> Entelos stages comeback bid with funding. Article
> AB Sciex, Indigo BioSystems join forces on mass spectrometry software. Story
> DecisionView updates clinical trial enrollment software. News
And Finally... A new "smart pill" that notifies patients about drug doses is set for sale in the U.K. this fall. Report